Nanomedicine for multimodality treatment of cancer-Reference-Cited by-同舟云学术

Nanomedicine for multimodality treatment of cancer

Published:2012-12 Issue:12 Volume:7 Page:1791-1794
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Mi Yu¹,Guo Yajun²,Feng Si-Shen³

Affiliation:

1. Department of Chemical & Biomolecular Engineering, National University of Singapore, Block E5, 02-09, 4 Engineering Drive 4, Singapore 117585, Singapore

2. PLA General Hospital Cancer Center, PLA Graduate School of Medicine, 28 Fuxing Road, Beijing 100853, China

3. Department of Chemical & Biomolecular Engineering, Department of Bioengineering, & Nanoscience & Nanotechnology Initiative (NUSNNI/NanoCore), National University of Singapore, Block E5, 02-09, 4 Engineering Drive 4, Singapore 117576, Singapore.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm.12.159

Reference21 articles.

1. Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases

2. Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

3. Chemotherapeutic Engineering: Concept, Feasibility, Safety and Prospect—A Tribute to Shu Chien’s 80th Birthday

4. Research Highlights

5. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and evaluation of RGD peptidomimetic – Gold nanostar conjugates as M21 cell adhesion inhibitors;Bioorganic Chemistry;2022-09

2. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells;The Korean Journal of Physiology & Pharmacology;2021-09-01

3. The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy;Journal of Controlled Release;2021-07

4. Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration;Small;2020-04-24

5. Biodistribution, Excretion, and Toxicity of Inorganic Nanoparticles;Theranostic Bionanomaterials;2019